The Clinical Core is organized to provide the clinical samples for all 4 projects. The core will have 4 functions: 1) to recruit and amange patients for the 3 protocols supporting the 4 projects, 2) to collect, process and catalogue all tissues (blood, lymph node, and GALT), 3) to assist the Administrative Core with tissue shipping and management of regulatory issues related to protocol administration, and 4) to maintain all patient and clinical laboratory records in a case report form and enter data into the established data base. Patients will be followed in the NIH funded General Clinical Research Center where all blood will be drawn and patients will receive required pre and post operative care. Tissues will receive initial processing through the clinical core and appropriate samples will be packed and shipped to off-site investigators. In addition, all clinical information (status, medications, clinical laboratory measures like CD4 and HIV viral load) will be maintained in a patient chart and entered into a central database by the nurse manager. Over the course of these projects we will recruit 70 individuals into 3 protocols that require lymph node and colon biopsy. We present data to show this goal is within the scope of recent accomplishments by our group. Protocol A will support Hypothesis 1 and distribute tissues to investigators in Projects 1, 2, and 4. Protocol B will support Hypothesis 2 and will distribute tissues to investigators in all 4 projects, and Protocol C will support Hypothesis 3 and distribute tissues to investigators in Projects 1, 2, and 4.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-CCH-A)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
United States
Zip Code
Cory, Theodore J; He, Hui; Winchester, Lee C et al. (2016) Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets. Pharm Res 33:2713-21
Lorenzo-Redondo, Ramon; Fryer, Helen R; Bedford, Trevor et al. (2016) Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530:51-56
Sanchez, Joyce L; Hunt, Peter W; Reilly, Cavan S et al. (2015) Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventions. J Infect Dis 211:1068-75
Winchester, Lee C; Podany, Anthony T; Baldwin, Joshua S et al. (2015) Determination of the rifamycin antibiotics rifabutin, rifampin, rifapentine and their major metabolites in human plasma via simultaneous extraction coupled with LC/MS/MS. J Pharm Biomed Anal 104:55-61
Cory, Theodore J; Winchester, Lee C; Robbins, Brian L et al. (2015) A rapid spin through oil results in higher cell-associated concentrations of antiretrovirals compared with conventional cell washing. Bioanalysis 7:1447-55
Mitchell, Caroline; Roemer, Emily; Nkwopara, Evangelyn et al. (2014) Correlation between plasma, intracellular, and cervical tissue levels of raltegravir at steady-state dosing in healthy women. Antimicrob Agents Chemother 58:3360-5
Fletcher, Courtney V; Staskus, Kathryn; Wietgrefe, Stephen W et al. (2014) Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A 111:2307-12
Misemer, Benjamin S; Skubitz, Amy P N; Carlos Manivel, J et al. (2014) Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity. Cancer Med 3:81-90
Podany, Anthony T; Winchester, Lee C; Robbins, Brian L et al. (2014) Quantification of cell-associated atazanavir, darunavir, lopinavir, ritonavir, and efavirenz concentrations in human mononuclear cell extracts. Antimicrob Agents Chemother 58:2866-70
Rizzardi, Anthony E; Vogel, Rachel Isaksson; Koopmeiners, Joseph S et al. (2014) Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors. Cancer 120:1800-9

Showing the most recent 10 out of 27 publications